Interesting blurb from Biotechmaven: BioTechMav

Quote:

---

BioTechMaven Sunday, 05/28/17 07:49:18 PM
Re: scottsmith post# 183500
Post # of 183571

With your flawed logic we should call a Phase 1 trial, a pre-pre clinical trial. And we should also discredit the countless Phase 2 trials with sub 30 patients that have successfully completed huge partnership or acquisition deals with big pharma. And while we are at it, we can also discount the endless deals in the countless billions by countless companies who did deals in pre-clinical (or using your method pre-pre-pre clinical!) Rather amusing the increasingly desperate attempts to attempt to create doubt when there is no doubt. I've seen a rash of posters here come in as of late from cowboys to generic names with what can only now be interpreted as desperate and quite frankly malicious attempts to discredit both company officers and the progress. I can offer one thought for you: science prevails.

Stay positive tomorrow is Memorial Day. Lots of fallen brothers and sisters to remember. No need to pay any attention to the usual suspects and their planned talking points.

Here's my unplanned talking point: Cellceutix is 43 days away from delivering topline data for Brilacidin Oral Mucositis and Brilacidin UC/IBD at a major conference in Boston, and perhaps 35 days and counting until Prurisol interim data can be unveiled.

That's three mid-phase phase two trials ready to reveal.

Fear the words 'mid-phase' if you're on the short end of the stick.

Good evening

---